You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 12, December 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Elevation of Serum Triglyceride Levels From Oral Isotretinoin in Disorders of Keratinization

Ronald A. Katz, MD; Hildegard Jorgensen, RN; Thomas P. Nigra, MD

Arch Dermatol. 1980;116(12):1369-1372.


Abstract

• Ten patients with disorders of keratinization were treated with oral isotretinoin (13-cis-retinoic acid) on an investigational protocol to test the efficacy, safety, and optimal dosage schedule for using the drug in these rare disorders. Elevations of serum triglyceride levels above the highest normal levels developed in seven of the ten patients, while they maintained normal levels of serum cholesterol. This effect was found to be dose and/or time related and reversible. Moderate elevations of serum triglyceride levels have not been clearly established as a risk factor for the development of coronary artery disease. High levels, however, may precipitate acute pancreatitis. For this reason, the conditions of patients receiving retinoids must be carefully monitored for triglyceride abnormalities throughout their courses of treatment.

(Arch Dermatol 116:1369-1372, 1980)



Author Affiliations

From the Department of Dermatology, The Washington Hospital Center, Washington, DC.


Footnotes

Accepted for publication March 13, 1980.

Reprint requests to the Department of Dermatology, The Washington Hospital Center, 110 Irving St NW, Washington, DC 20010 (Dr Katz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An Observational Study of Isotretinoin Recipients Treated for Acne in a Health Maintenance Organization
McElwee et al.
Arch Dermatol 1991;127:341-346.
ABSTRACT  

Dense Metaphyseal Bands and Growth Arrest Associated With Isotretinoin Therapy
Marini et al.
Arch Pediatr Adolesc Med 1988;142:316-318.
ABSTRACT  

Pancreatitis Associated with Isotretinoin-lnduced Hypertriglyceridemia
FLYNN et al.
ANN INTERN MED 1987;107:63-63.
ABSTRACT  

Acute Arthritis During Isotretinoin Treatment for Acne
Matsuoka et al.
Arch Intern Med 1984;144:1870-1871.
ABSTRACT  

Changes in Plasma Cholesterol and Triglyceride Levels After Treatment With Oral Isotretinoin: A Prospective Study
Zech et al.
Arch Dermatol 1983;119:987-993.
ABSTRACT  

Serum Triglyceride Elevation Following High-Dose Vitamin A Treatment for Pityriasis Rubra Pilaris
Murray et al.
Arch Dermatol 1983;119:675-676.
ABSTRACT  

Etretinate Therapy Causes Increases in Lipid Levels in Patients With Psoriasis
Ellis et al.
Arch Dermatol 1982;118:559-562.
ABSTRACT  

Retinoids, Cancer, and the Skin
Elias and Williams
Arch Dermatol 1981;117:160-180.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.